VIP
Description
Vasoactive Intestinal Peptide (VIP) is a 28-amino acid neuropeptide originally discovered in the gastrointestinal tract in 1970. Despite its name suggesting a primary role in the gut, VIP functions as a multifaceted signaling molecule throughout the body—acting in the nervous system, immune system, and various organ systems. It binds to two G-protein coupled receptors, VPAC1 and VPAC2, which are widely distributed across tissues. Research has demonstrated VIP's remarkable anti-inflammatory effects, with studies showing it can suppress pro-inflammatory cytokines, promote regulatory T cell function, and protect against tissue damage in multiple autoimmune disease models. Its neuroprotective properties, circadian rhythm regulation, and role in gut-brain axis communication have made it a subject of intense investigation for conditions ranging from inflammatory bowel disease to multiple sclerosis and Parkinson's disease.
Certificate of Analysis
Every batch of VIP is independently lab-tested to a minimum of 98% purity. A Certificate of Analysis is available on request — contact us with your order or lot number and we'll send the COA for your specific batch.
Request a COAFor laboratory and research use only. Minimum 98% purity. Supplied in sterile, flip-top headspace vials for laboratory use. Not intended for human or animal consumption, medical, diagnostic, therapeutic or veterinary use. These statements have not been evaluated by the MHRA or FDA. The purchaser accepts full responsibility for safe handling, storage and lawful use.